Does ZIDOVUDINE Cause Lipodystrophy acquired? 313 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 313 reports of Lipodystrophy acquired have been filed in association with ZIDOVUDINE (RETROVIR). This represents 4.7% of all adverse event reports for ZIDOVUDINE.
313
Reports of Lipodystrophy acquired with ZIDOVUDINE
4.7%
of all ZIDOVUDINE reports
1
Deaths
42
Hospitalizations
How Dangerous Is Lipodystrophy acquired From ZIDOVUDINE?
Of the 313 reports, 1 (0.3%) resulted in death, 42 (13.4%) required hospitalization, and 10 (3.2%) were considered life-threatening.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZIDOVUDINE. However, 313 reports have been filed with the FAERS database.
What Other Side Effects Does ZIDOVUDINE Cause?
Foetal exposure during pregnancy (1,816)
Virologic failure (741)
Exposure during pregnancy (575)
Drug resistance (568)
Pathogen resistance (552)
Viral mutation identified (531)
Treatment failure (409)
Maternal exposure during pregnancy (395)
Anaemia (380)
Premature baby (367)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
ABACAVIR (194)
Which ZIDOVUDINE Alternatives Have Lower Lipodystrophy acquired Risk?
ZIDOVUDINE vs ZILEUTON
ZIDOVUDINE vs ZILUCOPLAN
ZIDOVUDINE vs ZIMBERELIMAB
ZIDOVUDINE vs ZINC
ZIDOVUDINE vs ZINC\ZINC